Merck & Co Inc (NYSE:MRK)
| 78.13 Delayed Data As of Jul 28 |  +0.28 / +0.36%Today’s Change | 68.38 Today|||52-Week Range 83.72 | +0.17% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 77.85 |
| Today’s open | 77.85 |
| Day’s range | 77.48 - 78.66 |
| Volume | 11,037,871 |
| Average volume (3 months) | 11,796,758 |
| Market cap | $196.3B |
Data as of 4:00pm ET, 07/28/2021
Growth & Valuation
| Earnings growth (last year) | -27.21% |
| Earnings growth (this year) | +3.32% |
| Earnings growth (next 5 years) | +7.80% |
| Revenue growth (last year) | +3.06% |
| P/E ratio | 28.3 |
| Price/Sales | 4.33 |
| Price/Book | 7.75 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.58 | +0.63% |
| ABBVAbbVie | +0.57 | +0.48% |
| AZNAstraZeneca | -0.64 | -1.11% |
| LLYEli Lilly and Co | +2.91 | +1.19% |
Data as of 4:00pm ET, 07/28/2021
Financials
| Last reporting date | July 29, 2021 |
| EPS forecast (this quarter) | $1.33 |
| Annual revenue (last year) | $48.0B |
| Annual profit (last year) | $7.1B |
| Net profit margin | 14.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
